TSS
JAZZ icon

Two Sigma Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Two Sigma Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,700
Closed -$211K – 3212
2023
Q2 		$211K Buy
+1,700
New +$229K ﹤0.01% 2174
2022
Q2 		– Sell
-3,600
Closed -$560K – 2553
2022
Q1 		$560K Buy
+3,600
New +$522K 0.02% 929

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Two Sigma Securities's JAZZ Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 1,065 shares worth $201K. The stake represents 0.02% of the portfolio and ranks #1052 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in JAZZ as recently as Q2 2024.

Two Sigma Securities first reported a position in JAZZ in Q4 2016 and has held it in 12 quarters since. The position peaked at $411K in Q2 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Two Sigma Securities held 1,065 shares of Jazz Pharmaceuticals worth $201K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1052 holding.
  • Two Sigma Securities first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
  • Two Sigma Securities's Jazz Pharmaceuticals position peaked at $411K in Q2 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.